Citigroup Maintains Neutral on Healthcare Realty Trust, Lowers Price Target to $17
Portfolio Pulse from Benzinga Newsdesk
Citigroup analyst Michael Griffin maintains a Neutral rating on Healthcare Realty Trust (NYSE:HR) and lowers the price target from $19 to $17.
August 22, 2023 | 2:57 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Citigroup has maintained a Neutral rating on Healthcare Realty Trust and lowered the price target from $19 to $17.
The lowering of the price target by Citigroup indicates a potential decrease in the stock's value. This could lead to a negative short-term impact on the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100